Evaluation of Untargeted Metabolomic Strategy for the Discovery of Biomarker of Breast Cancer

Discovery of disease biomarker based on untargeted metabolomics is informative for pathological mechanism studies and facilitates disease early diagnosis. Numerous of metabolomic strategies emerge due to different sample properties or experimental purposes, thus, methodological evaluation before sam...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Xujun, Wang, Yan, Zhou, Lirong, Zheng, Qiuling, Hao, Haiping, He, Dandan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189413/
https://www.ncbi.nlm.nih.gov/pubmed/35707402
http://dx.doi.org/10.3389/fphar.2022.894099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189413/
https://www.ncbi.nlm.nih.gov/pubmed/35707402
http://dx.doi.org/10.3389/fphar.2022.894099

Ejemplares similares